Standard BioTools financial statements
스탠더드 바이오툴스NASDAQ:LAB · Nasdaq · Healthcare$0.7447+2.25%
2026-10-02 closeStandard BioTools's published financial data is dated 2026-10-04. 2024 revenue was $174M. 2024 operating profit was −$150M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy